Jeremy Hall
Has grant
Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Open
Developing Minds
Open Date: 2024-09-01
Close Date: 2030-07-01
Grant: Open
The Hodge Centre for Translational Neuroscience
Open Date: 2023-04-01
Close Date: 2028-04-01
Grant: Open
The impact of schizophrenia-associated copy number variants on cortical network dynamics
Open Date: 2023-03-01
Close Date: 2028-04-01
Articles (11)
Year:
2026
Year:
2026
Background Longitudinal studies have revealed that raised levels of inflammatory markers and trauma in childhood are associated with psychopathology in adulthood. Aims To examine whether inflammation in childhood mediates the effects of genetic risk and trauma on psychopathology in early adulthood. Method Measures of trauma exposure, inflammation and psychopathology were collected from the Avon Longitudinal Study of Parents and Children. Exposure to trauma was measured from 5 to 11 years of age; C-reactive protein and interleukin-6 levels were measured at 9 years; and depression, anxiety disorders, negative symptoms and psychotic experiences were assessed at 24 years. Polygenic risk scores (PRSs) were created for schizophrenia, depression, anxiety and psychotic experiences. Mediation analyses were conducted using imputed data ( N : 7859 to 8700) to investigate whether inflammation mediated the associations of genetic risk and childhood trauma with psychopathology. Results Most psychiatric PRSs were associated with multiple psychopathological outcomes in adulthood, with the exception of the PRS for psychotic experiences. Childhood trauma was associated with all psychopathology. However, there was no strong evidence that inflammatory markers in childhood mediated associations among PRSs, trauma and psychopathology. Sensitivity analyses using outcomes from age 18 and PRSs based on single-nucleotide polymorphisms that met more stringent standards of evidence of association gave results consistent with those of our primary analyses. Conclusions We found little evidence that interleukin-6 or C-reactive protein mediated the pathway between genetic liability for psychiatric phenotypes or trauma and subsequent psychopathology. Longitudinal investigation of other inflammatory and non-inflammatory pathways is required to identify modifiable targets and inform novel treatment strategies for individuals at genetic or trauma-related risk of psychiatric illness.
Year:
2025
Background Children and young people with intellectual and developmental disabilities (IDDs) face challenges across various aspects of their lives and require significant support, particularly in the field of education. In the United Kingdom, Education, Health and Care Plans (EHCPs) support those with special educational needs (SEN) in schools. Disparities exist throughout our national educational system with respect to how long pupils with IDDs must wait for an EHCP, but the socio‐demographic influences on those disparities are currently unknown. Delays in providing EHCP support result in negative educational, wellbeing and developmental outcomes. Using data from the National Pupil Database (NPD), we examined variabilities in waiting times for EHCP provision, and correlations with potentially influential variables such as SEN classification, family socio‐economic status, region of domicile and ethnicity. Methods This national study recruited 2131 participants [6–28 years old, mean (SD) = 14.1 (4.4) years] with IDDs associated with a genetic condition. Families gave consent for their child's educational records to be reviewed by the research team. All participants had received an EHCP at some point during their full‐time education in England. We accessed the NPD (provided by the UK Department for Education), for details of participants' primary SEN type, free school meal eligibility, ethnicity and the academic year in which they received an EHCP. Based on their home address postcode, we assigned to each family an index of multiple deprivation (IMD) score. From the NPD, we calculated the waiting time between a child's recommendation for an EHCP and the time they received it. We compared these data with IMD scores, primary SEN type, free school meal eligibility, English region of domicile, ethnicity, and sex. We used linear regression models to examine the associations between the predictors (the above demographic independent variables) and the duration of time it took for children to receive an EHCP. Results Participants with IDDs of genetic aetiology who lived in the most socially deprived regions of England waited longer for EHCP support than those in the least deprived regions, irrespective of the NPD classification of the child's SEN type. Neither the child's ethnicity nor their sex had any added impact. Whatever their IMD status, participants living in London obtained an EHCP more quickly than those living elsewhere in England. Conclusions There are nationwide inconsistencies in the time taken to provide EHCPs to children and young people whose intellectual impairments are of known genetic aetiology. Regional inequalities in the funds available to local education authorities could be a major contributory factor.
Year:
2025
Antipsychotic medications targeting dopamine receptors were identified 70 years ago. Recent clinical trials have shown that agonists of muscarinic acetylcholinergic receptors can improve both psychotic and negative symptoms in schizophrenia. Here, this new approach to the treatment of schizophrenia is reviewed in anticipation of the drugs being licensed clinically.
Year:
2025
Background CACNA1C encodes the pore-forming subunit of the L-type calcium channel Cav1.2. Common variants in CACNA1C are associated with psychiatric disorders, while rare single-nucleotide variants cause CACNA1C-related disorder (CRD), a multi-system disorder with symptoms that include autism spectrum disorder (ASD), intellectual disability and seizures. However, the cellular mechanisms linking CACNA1C dysfunction to neurodevelopmental phenotypes remain poorly understood. Methods We generated isogenic CACNA1C loss-of-function (LoF) induced pluripotent stem cell (iPSC) lines and reprogrammed a line from an individual carrying a novel gain-of-function (GoF) variant in CACNA1C . Neuronal activity was assessed using multi-electrode arrays (MEA), pharmacological manipulation, and gene expression analysis. Early developmental phenotypes were examined using qRT-PCR, immunocytochemistry, and RNA sequencing. Results LoF and GoF patient-derived neurons displayed opposing alterations in network dynamics. Pharmacological and molecular assays indicated that these network differences were associated with dysregulated GABAergic signalling. Early developmental analysis revealed that loss of CACNA1C altered rosette morphology, CREB phosphorylation, and transcriptional programs related to axonogenesis and synaptic signalling, indicating effects on neuronal differentiation. The patient line exhibited opposing phenotypes, reflecting variant-specific effects. Conclusions These findings demonstrate that Cav1.2 regulates excitatory–inhibitory balance, network organization, and aspects of neurodevelopment. Divergent effects of LoF and GoF variants highlight how altered Cav1.2 signalling contributes to variable neurodevelopmental phenotypes, including ASD and epilepsy, and establish a framework for defining CACNA1C variant effects in human neurons.
Year:
2025
Latent inhibition (LI) has been extensively studied to investigate associative learning and memory processes as well as modelling aberrant attribution of salience to irrelevant stimuli in both humans and animals, a process which is thought to underpin hallucinations and delusions in psychosis. Despite sex differences observed in numerous aspects of psychosis, few studies have attempted to characterise sex differences in LI. This systematic review outlines the current evidence of sex differences in LI in both human and rodent studies, showing predominantly inconclusive and conflicting evidence for sex differences. We present data demonstrating sex differences in latent inhibition of contextual fear conditioning and associated gene expression in the hippocampus in rodents, supporting sex differences in latent inhibition at the behavioural and neurobiological levels. The systematic review suggests that although there have been relatively few studies of sex differences in LI, the data suggest that in hippocampally dependent forms of LI, sex differences may be more apparent, which may be of relevance in relation to sex differences in the presentation of psychosis.
Year:
2025
Background Physical health conditions are more common in individuals with autism. Some, like epilepsy, have considerable evidence supporting their increased prevalence, but many diseases lack literature to make strong conclusions. Aims To investigate the prevalence of physical health comorbidities in autism. Method We undertook a nested cross-sectional study, using a sample from the National Centre for Mental Health database. It included participants from England and Wales who reported a clinician-made diagnosis of autism ( n = 813), and a control sample without autism or mental illness ( n = 2781). Participants had provided a medical history at enrolment. Analysis was carried out by binomial logistic regressions controlling for age, gender, smoking status, and antipsychotic and mood stabiliser use. A subanalysis of individuals with concurrent intellectual disability ( n = 86) used binomial logistic regression with the same control variables. Results Many physical health conditions were significantly more common in autism. Sixteen out of 28 conditions showed increased odds, with the highest odds ratios observed for liver disease, chronic obstructive pulmonary disease, kidney disease, osteoporosis and rheumatoid arthritis. A subanalysis demonstrated a similar pattern of physical health in individuals with autism with and without concurrent intellectual disability. Some conditions, including osteoporosis, hyperthyroidism, head injury and liver disease, had larger odds ratios in individuals with concurrent intellectual disability. Conclusions Physical health conditions occur more commonly in individuals with autism, and certain conditions are further increased in those with concurrent intellectual disability. Our findings contribute to prior evidence, including novel associations, and suggest that people with autism are at greater risk of physical health problems throughout adulthood.
Year:
2024
Common and rare variation in CACNA1C gene expression has been consistently associated with neuropsychiatric disorders such as schizophrenia, bipolar disorder, and major depression, however the underlying biological pathways that cause this association have yet to be fully determined. In this study, we present evidence that rats with a reduced gene dosage of Cacna1c have increased basal corticosterone levels in the periphery and reduced Nr3c1 gene expression in the hippocampus and hypothalamus. These results are consistent with an effect of Cacna1c dosage on hypothalamus-pituitary-adrenal (HPA) axis function. We also show that the reduction of Nr3c1 in the hippocampus may be caused by epigenetic modification of exon 1 7 of Nr3c1 , including the reduced interaction with the histone modifying markers H3K4me3 and H3K27ac. Heterozygous Cacna1c rats additionally show increased anxiety behaviours. These results support an association of Cacna1c heterozygosity with the altered activity of the HPA axis and function in the resting state and this may be a predisposing mechanism that contributes to the increased risk of psychiatric disorders with stress.
Year:
2024
A range of rare mutations involving micro-deletion or -duplication of genetic material (copy number variants (CNVs)) have been associated with high neurodevelopmental and psychiatric risk (ND-CNVs). Irritability is frequently observed in childhood neurodevelopmental conditions, yet its aetiology is largely unknown. Genetic variation may play a role, but there is a sparsity of studies investigating the presentation of irritability in young people with ND-CNVs. This study aimed to investigate whether there is a difference in irritability in young people with rare ND-CNVs compared to those without ND-CNVs, and to what extent irritability is associated with psychiatric diagnoses and cognitive ability (IQ). Irritability and broader psychopathology were assessed in 485 young people with ND-CNVs and 164 sibling controls, using the child and adolescent psychiatric assessment. Autism was assessed using the social communication questionnaire, and intelligence quotient (IQ) by the Wechsler abbreviated scale of intelligence. Fifty four percent of young people with ND-CNVs met the threshold for irritability; significantly more than controls (OR = 3.77, CI = 3.07–7.90, p = 5.31 × 10 −11 ). When controlling for the presence of other psychiatric comorbidities, ND-CNV status was still associated with irritability. There was no evidence for a relationship between irritability and IQ. Irritability is an important aspect of the clinical picture in young people with ND-CNVs. This work shows that genetic variation is associated with irritability in young people with ND-CNVs, independent of psychiatric comorbidities or IQ impairment. Clinicians should be aware of this increased risk to inform management and interventions.
Year:
2024
Year:
2024
Collaborators (18)
Alexander Shaw
Senior Lecturer
University of Exeter
David Skuse
University College London
Carrie Bearden
Professor
University of California, Los Angeles
Danilo Bzdok
-
Stanley Zammit
Professor of Psychiatric Epidemiology
University of Bristol
Kerrie Thomas
Reader
Cardiff University
Gemma Hammerton
Academic , Senior Lecturer
University of Bristol
Marianne van den Bree
Professor
Cardiff University
Adrian Harwood
Profressor
Cardiff University
Jeanne Wolstencroft
Senior Research Fellow
University College London
Hannah J Jones
Academic , Senior Research Fellow
University of Bristol
Peter Holmans
Professor of Biostatistics and Genetic Epidemiology
Cardiff University
Bogdan Draganski
Head Memory Clinic
University Hospital of Bern
Dominic Dwyer
Professor
Cardiff University
Jakub Kopal
University of Oslo
Ole A. Andreassen
Oslo University Hospital
Mouhamed Alsaqati
Lecturer in Neuropharmacology
Newcastle University
Matt Jones
Academic , Professor in Neuroscience
University of Bristol
Make your next move.
Prepare your application
Review drafts before you send them.